145 related articles for article (PubMed ID: 11342931)
1. Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy.
Pavlovich CP; Battiwalla M; Rick ME; Walther MM
J Urol; 2001 May; 165(5):1617. PubMed ID: 11342931
[No Abstract] [Full Text] [Related]
2. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
Rodgers GM
J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated coagulopathy: a case report.
Naoum JJ
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
[TBL] [Abstract][Full Text] [Related]
4. Bovine thrombin and the clinical consequence of antibody development.
Cronstein BN
J Am Coll Surg; 2008 Jan; 206(1):199; author reply 199-200. PubMed ID: 18155591
[No Abstract] [Full Text] [Related]
5. Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
Voils SA
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):18S-22S. PubMed ID: 19558281
[TBL] [Abstract][Full Text] [Related]
6. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.
Adams JD; Jones S; Brost BC
J Reprod Med; 2001 Oct; 46(10):909-12. PubMed ID: 11725736
[TBL] [Abstract][Full Text] [Related]
7. Bovine thrombin: history, use, and risk in the surgical patient.
Diesen DL; Lawson JH
Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
[TBL] [Abstract][Full Text] [Related]
8. Antihuman factor V antibodies after use of relatively pure bovine thrombin.
Lawson JH; Lynn KA; Vanmatre RM; Domzalski T; Klemp KF; Ortel TL; Niklason LE; Parker W
Ann Thorac Surg; 2005 Mar; 79(3):1037-8. PubMed ID: 15734434
[TBL] [Abstract][Full Text] [Related]
9. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
[TBL] [Abstract][Full Text] [Related]
10. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
11. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
Lo CY; Jones C; Glader B; Zehnder JL
Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
[TBL] [Abstract][Full Text] [Related]
12. The coagulation cascade and surgical hemostasis. Introduction.
Voils SA
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):1S. PubMed ID: 19558277
[No Abstract] [Full Text] [Related]
13. Cross-reactivity of rabbit anti-bovine thrombin IgGs with human alpha-thrombin and a recombinant version of human thrombin (Recothrom).
He Zhu ; Hoppensteadt D; Cunanan J; Fareed J
Clin Appl Thromb Hemost; 2010 Jun; 16(3):273-80. PubMed ID: 20547555
[TBL] [Abstract][Full Text] [Related]
14. Persistence of antibodies to the topical hemostat bovine thrombin.
Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
[TBL] [Abstract][Full Text] [Related]
15. Immune responses associated with perioperative exposure and reexposure to topical bovine thrombin do not impair hemostasis.
Paterson CA; Pixton GC; Proskin HM; Massaro JM; Morasch M; Cronstein B; Fareed J; Ofosu FA
Clin Appl Thromb Hemost; 2011; 17(6):620-32. PubMed ID: 21596694
[TBL] [Abstract][Full Text] [Related]
16. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
17. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
Bomgaars L; Carberry K; Fraser C; West A; Teruya J
Congenit Heart Dis; 2010; 5(3):303-8. PubMed ID: 20576051
[TBL] [Abstract][Full Text] [Related]
18. Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin.
Crow SS; Sullivan VV; Aysola AE; Key NS; Harker-Murray P; Foker JE; Steiner ME
Ann Thorac Surg; 2007 Apr; 83(4):1547-9. PubMed ID: 17383385
[TBL] [Abstract][Full Text] [Related]
19. Achieving hemostasis in the surgical field.
Boucher BA; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):2S-7S. PubMed ID: 19558278
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
